(Q44191663)

English

Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

Józef Krzysiek

3

object named as

Krzysiek J

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Milewicz T

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kolodziejczyk J

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Basta A

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sztefko K

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kurek S

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Stachura J

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gregoraszczuk EL

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

319-329

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Effects of oral contraceptives on breast epithelial proliferation

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives.

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Oral contraceptives and cancer: an update

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Growth hormone induces tyrosyl phosphorylation of the transcription factors Stat5a and Stat5b in CMT-U335 canine mammary tumor cells

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Structure and function of the type 1 insulin-like growth factor receptor.

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Atypical hyperplasia, proliferative fibrocystic change, and exogenous hormone use.

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activity

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

N-(n-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Controlling IGF-receptor function: a possible strategy for tumor therapy

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Mechanisms of antineoplastic action of somatostatin analogs

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Role of androgens in proliferation and differentiation of mouse mammary epithelial cell line HC11.

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells.

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.4.319.329

21 January 2018

Identifiers

10.1080/GYE.16.4.319.329

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44191663&oldid=2108383556"